Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)
October 03 2022 - 08:00AM
Edgar (US Regulatory)
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 6-K
REPORT OF FOREIGN PRIVATE ISSUER
PURSUANT TO RULE 13a-16 OR 15d-16
UNDER THE SECURITIES EXCHANGE ACT OF 1934
For the date of October 3, 2022
Commission File Number 001-39124
Centogene N.V.
(Translation of registrant's name into English)
Am Strande 7
18055 Rostock
Germany
(Address of
principal executive offices)
Indicate by check mark whether the registrant files or will file
annual reports under cover of Form 20-F or Form 40-F.
Form 20-F..X.. Form 40-F.....
Indicate by check mark if the registrant is submitting the Form 6-K
in paper as permitted by Regulation S-T Rule 101(b)(1): ___
Indicate by check mark if the registrant is submitting the Form 6-K
in paper as permitted by Regulation S-T Rule 101(b)(7): ____
Centogene N.V.
On October
3, 2022, Centogene N.V. issued a press release titled “CENTOGENE
Reaches 12,500 Patient Milestone in World’s Largest Observational
Study on Parkinson’s Disease Genetics”.
A copy of the press release is attached hereto as Exhibit 99.1.
Signatures
Pursuant to the requirements of the Securities Exchange Act of
1934, the registrant has duly caused this report to be signed on
its behalf by the undersigned, thereunto duly authorized.
Date: October 3, 2022
|
CENTOGENE N.V.
|
|
| |
|
|
|
| |
|
|
|
| By: |
/s/ Jose Miguel Coego Rios |
|
| |
Name: |
Jose Miguel Coego
Rios |
|
| |
Title: |
Chief Financial
Officer |
|
Exhibit Index
| Exhibit |
Description of Exhibit |
| |
|
| 99.1 |
Press Release dated October 3,
2022 |
Centogene NV (NASDAQ:CNTG)
Historical Stock Chart
From Mar 2023 to Mar 2023
Centogene NV (NASDAQ:CNTG)
Historical Stock Chart
From Mar 2022 to Mar 2023
